IM Cannabis Corp (NAS:IMCC)
$ 0.13 +0.0051 (+4.08%) Market Cap: 1.17 Mil Enterprise Value: 11.08 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q2 2024 IM Cannabis Corp Earnings Call Transcript

Aug 14, 2024 / 01:00PM GMT
Release Date Price: $2.99 (+8.33%)

Key Points

Positve
  • IM Cannabis Corp (IMCC) experienced a significant increase in sales in Germany, with a 200% growth in Q2 2024 compared to Q1 2024, following the legalization of cannabis in Germany.
  • The company reported an 11.7% increase in revenue in Q2 2024 compared to Q2 2023, driven by strong performance in the German market.
  • IM Cannabis Corp (IMCC) has successfully increased its selling price per gram of dried flower by 21% year-over-year, reaching $6.09 per gram.
  • The company has strategically focused on the premium and ultra-premium segments in Israel, launching new strains and brands to strengthen its market position.
  • IM Cannabis Corp (IMCC) has reduced its operating expenses by 29% in Q2 2024 compared to Q2 2023, reflecting effective cost management and restructuring efforts.
Negative
  • The company's gross profit decreased by 75.6% in Q2 2024 compared to Q2 2023, primarily due to clearing old inventory and accruing for slow-moving stock.
  • IM Cannabis Corp (IMCC) reported a non-IFRS adjusted EBITDA loss of $2.3 million in Q2 2024, a significant increase from the $0.5 million loss in Q2 2023.
  • The company's cash and cash equivalents decreased to $0.7 million as of June 30, 2024, from $1.8 million at the end of 2023, indicating potential liquidity concerns.
  • Total assets decreased by 17.6% as of June 30, 2024, compared to December 31, 2023, largely due to the cancellation of the Oranim agreement.
  • IM Cannabis Corp (IMCC) faces challenges in maintaining gross margins, with significant inventory clearance and accruals impacting financial performance.
Operator

Good morning, and welcome to IM Cannabis' second-quarter 2024 earnings conference call. Today's conference call is being recorded. At this time, I would like to turn the conference call over to Anna Taranko, Director of Investor and Public Relations. Anna?

Anna Taranko
IM Cannabis Corp - Director Investor & Public Relations

Good morning, and thank you, operator. Joining me for today's call are IM Cannabis' Chief Executive Officer, Oren Shuster; and Chief Financial Officer, Uri Birenberg. The earnings press release that accompanies this call is available on the Investor Relations section of our website at investors.imcannabis.com.

Today's call will include estimates and other forward-looking information and statements, including statements concerning future results of operations, economic conditions and anticipated courses of action and are based on assumptions, expectations, estimates, and projections as of the date hereof. This information may involve known and unknown risks, uncertainties and other factors that may cause actual results to differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot